371 related articles for article (PubMed ID: 37497699)
21. The role of filgotinib in ulcerative colitis and Crohn's disease.
Fanizza J; D'Amico F; Lauri G; Martinez-Dominguez SJ; Allocca M; Furfaro F; Zilli A; Fiorino G; Parigi TL; Radice S; Peyrin-Biroulet L; Danese S
Immunotherapy; 2024 Feb; 16(2):59-74. PubMed ID: 38009327
[TBL] [Abstract][Full Text] [Related]
22. Serum inter-alpha-trypsin inhibitor heavy chain 4 in patients with inflammatory bowel disease: correlation with disease risk, inflammation, activity, and its variation after treatment.
Wen N; Zhao N; Xu H; Zhao Y; Ma J
Ir J Med Sci; 2022 Oct; 191(5):2105-2111. PubMed ID: 34843071
[TBL] [Abstract][Full Text] [Related]
23. Inflammatory bowel disease. Part I: Nature and pathogenesis.
Kirsner JB
Dis Mon; 1991 Oct; 37(10):605-66. PubMed ID: 1893828
[TBL] [Abstract][Full Text] [Related]
24. Cannabis use amongst patients with inflammatory bowel disease.
Lal S; Prasad N; Ryan M; Tangri S; Silverberg MS; Gordon A; Steinhart H
Eur J Gastroenterol Hepatol; 2011 Oct; 23(10):891-6. PubMed ID: 21795981
[TBL] [Abstract][Full Text] [Related]
25. A descriptive study of inflammatory bowel disease at an Egyptian tertiary care center.
El-Atrebi KA; Taher E; El Aguizy FH; Ali RM; Hegazy A; El-Sayed MM; Eysa B; El-Atreby AA; Mohammed AA; El-Bassyouni HT
Rev Gastroenterol Mex (Engl Ed); 2023; 88(1):12-18. PubMed ID: 34887218
[TBL] [Abstract][Full Text] [Related]
26. Nanomedicine-mediated drug delivery for potential treatment of inflammatory bowel disease: a narrative review.
Ardekani ZM; Lorenzo-Leal AL; Bach H
Nanomedicine (Lond); 2024 Jan; 19(2):163-179. PubMed ID: 38284393
[No Abstract] [Full Text] [Related]
27. Inflammatory Bowel Disease: An Overview of Immune Mechanisms and Biological Treatments.
de Mattos BR; Garcia MP; Nogueira JB; Paiatto LN; Albuquerque CG; Souza CL; Fernandes LG; Tamashiro WM; Simioni PU
Mediators Inflamm; 2015; 2015():493012. PubMed ID: 26339135
[TBL] [Abstract][Full Text] [Related]
28. Inflammatory bowel disease. Part II: Clinical and therapeutic aspects.
Kirsner JB
Dis Mon; 1991 Nov; 37(11):669-746. PubMed ID: 1935537
[TBL] [Abstract][Full Text] [Related]
29. The genetics of Crohn's disease and ulcerative colitis--status quo and beyond.
Ellinghaus D; Bethune J; Petersen BS; Franke A
Scand J Gastroenterol; 2015 Jan; 50(1):13-23. PubMed ID: 25523552
[TBL] [Abstract][Full Text] [Related]
30. IBD-PODCAST Spain: A Close Look at Current Daily Clinical Practice in IBD Management.
Vega P; Huguet JM; Gómez E; Rubio S; Suarez P; Vera MI; Paredes JM; Hernández-Camba A; Plaza R; Mañosa M; Pajares R; Sicilia B; Madero L; Kolterer S; Leitner C; Heatta-Speicher T; Michelena N; Santos de Lamadrid R; Dignass A; Gomollón F
Dig Dis Sci; 2024 Mar; 69(3):749-765. PubMed ID: 38217680
[TBL] [Abstract][Full Text] [Related]
31. Changes in incidence and clinical features of inflammatory bowel disease in Cardiff, UK over 50 years: an update for 2005-2016.
Arms-Williams B; Hawthorne AB; Cannings-John R; Berry A; Harborne P; Trivedi A
Scand J Gastroenterol; 2023 Jun; 58(6):619-626. PubMed ID: 36562277
[TBL] [Abstract][Full Text] [Related]
32. The potential therapeutic role of vitamin D in inflammatory bowel disease.
Boccuzzi L; Infante M; Ricordi C
Eur Rev Med Pharmacol Sci; 2023 May; 27(10):4678-4687. PubMed ID: 37259751
[TBL] [Abstract][Full Text] [Related]
33. Mucosal Expression of Type 2 and Type 17 Immune Response Genes Distinguishes Ulcerative Colitis From Colon-Only Crohn's Disease in Treatment-Naive Pediatric Patients.
Rosen MJ; Karns R; Vallance JE; Bezold R; Waddell A; Collins MH; Haberman Y; Minar P; Baldassano RN; Hyams JS; Baker SS; Kellermayer R; Noe JD; Griffiths AM; Rosh JR; Crandall WV; Heyman MB; Mack DR; Kappelman MD; Markowitz J; Moulton DE; Leleiko NS; Walters TD; Kugathasan S; Wilson KT; Hogan SP; Denson LA
Gastroenterology; 2017 May; 152(6):1345-1357.e7. PubMed ID: 28132889
[TBL] [Abstract][Full Text] [Related]
34. A galectin-specific signature in the gut delineates Crohn's disease and ulcerative colitis from other human inflammatory intestinal disorders.
Papa Gobbi R; De Francesco N; Bondar C; Muglia C; Chirdo F; Rumbo M; Rocca A; Toscano MA; Sambuelli A; Rabinovich GA; Docena GH
Biofactors; 2016; 42(1):93-105. PubMed ID: 26891020
[TBL] [Abstract][Full Text] [Related]
35. Use of antibiotics in the treatment of inflammatory bowel disease.
Perencevich M; Burakoff R
Inflamm Bowel Dis; 2006 Jul; 12(7):651-64. PubMed ID: 16804403
[TBL] [Abstract][Full Text] [Related]
36. [Ulcerative colitis].
Lopetuso L; Gasbarrini A
Recenti Prog Med; 2016 Jun; 107(6):297-308. PubMed ID: 27362722
[TBL] [Abstract][Full Text] [Related]
37. Lymphocyte homing and its role in the pathogenesis of IBD.
Eksteen B; Liaskou E; Adams DH
Inflamm Bowel Dis; 2008 Sep; 14(9):1298-312. PubMed ID: 18393377
[TBL] [Abstract][Full Text] [Related]
38. Emerging pharmacotherapy for inflammatory bowel diseases.
Luo H; Cao G; Luo C; Tan D; Vong CT; Xu Y; Wang S; Lu H; Wang Y; Jing W
Pharmacol Res; 2022 Apr; 178():106146. PubMed ID: 35227890
[TBL] [Abstract][Full Text] [Related]
39. [ECONOMIC BURDEN AND CURRENT STATUS OF THE DRUG SUPPLY MANAGEMENT FOR IMMUNE INFLAMMATORY DISEASES (BY EXAMPLE OF ULCERATIVE COLITIS AND CROHN'S DISEASE)].
Veselov AV; Belousova EA; Bakulin IG; Uspenskiy YP; Dreval RO; Shkurko TV; Kashnikov BN; Fominykh YA; Knyazev OV; Romanov RI; Skalinskaia MI; Shipitsyn VV
Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med; 2020 Oct; 28(Special Issue):1137-1145. PubMed ID: 33219771
[TBL] [Abstract][Full Text] [Related]
40. A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease.
Seyedian SS; Nokhostin F; Malamir MD
J Med Life; 2019; 12(2):113-122. PubMed ID: 31406511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
